Cost effective analysis of metformin plus glimepiride plus voglibose compared with glicazide plus metformin plus voglibose in type 2 diabetes mellitus patients
Jerlin elza joseph, jidin a jawad, neethu anand
Date : 2019-06-15
Views : 1404
Download : 343
ABSTRACT
BACKGROUND: Costly treatment in chronic lifelong diseases like diabetes mellitus imposes a substantial economic burden on the society. In a developing country like India making the treatme...
